Skip to main content
Log in

Positive gallium-67 and thallium-201 scans in thymic rebound after chemotherapy for lymphoma

  • Case Report
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

It is a diagnostic problem to distinguish thymic rebound or rebound thymic hyperplasia from thymic malignancy, but it is frequently made more difficult because most patients have had previous malignancies. Recently we evaluated a six-year-old girl with thymic rebound after chemotherapy for lymphoma, by both gallium-67 and thallium-201 scans. On gallium-67 scan, intensive uptake was seen in the anterior mediastinum. CT revealed a triangular-shaped, homogeneous mass in the anterior mediastinum. On early scan of thallium-201 study, slight accumulation was seen in the anterior mediastinum and was enhanced in delayed scans. Considering the clinical state and imaging results, thymic rebound after chemotherapy was the most likely diagnosis, and follow-up observation was done without therapy. During the course, there were no signs of relapse. Some reports have described both positive and negative thallium-201 accumulation in thymic rebound. Although more experience with similar cases is necessary, it is likely that thallium-201 also tends to accumulate in thymic rebound as well as gallium-67.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cohen M, Hill CA, Cangir A, Sullivian MP. Thymic rebound after treatment of childhood tumors.AJR 1980; 135: 151–156.

    PubMed  CAS  Google Scholar 

  2. Donahue DM, Leonard JC, Basmadjian GP, Nitschke RM, Hinkle GH, Ice RD, et al. Thymic gallium-67 localization in pédiatrie patients on chemotherapy: concise communication.J Nucl Med 1981; 22: 1043–1048.

    PubMed  CAS  Google Scholar 

  3. Choyke PL, Zetnan RK, Gootenberg JE, Greenberg JN, Hoffer F, Frank JA. Thymic atrophy and regrowth in response to chemotherapy: CT evaluation.AJR 1987; 149: 269–272.

    PubMed  CAS  Google Scholar 

  4. Harris EW, Rakow JI, Weiner M, Agres HJr. Thallium-201 scintigraphy for assessment of a Gallium-67-avid mediastinal mass following therapy for Hodgkin’s disease.J Nucl Med 1993; 34: 1326–1330.

    PubMed  CAS  Google Scholar 

  5. Luker GD, Siegel MJ. Mediastinal Hodgkin disease in children: response to therapy.Radiology 1993; 189: 737–740.

    PubMed  CAS  Google Scholar 

  6. Kissin CM, Husband JE, Nicholas D, Eversman W. Benign thymic enlargement in adults after chemotherapy: CT demonstration.Radiology 1987; 163: 67–70.

    PubMed  CAS  Google Scholar 

  7. Heron CW, Husband JE, Williams MP. Hodgkin disease: CT of the thymus.Radiology 1988; 167:647–651.

    PubMed  CAS  Google Scholar 

  8. Drossmann SR, Schiff RG, Kronfeld GD, McNamara J, Leonidas JC. Lymphoma of the mediastinum and neck: evaluation with Ga-67 imaging and CT correlation.Radiology 1990; 174: 171–175.

    Google Scholar 

  9. Fletcher BD, Kauffman WM, Kaste SC, Winer-Muran HT, Fang L, Chen G, et al. Use of Tl-201 to detect pediatric Hodgkin disease.Radiology 1995; 196: 851–855.

    PubMed  CAS  Google Scholar 

  10. Roebuck DJ, Wayne D, Nicholls WD, Bernard EJ, Kellie SJ, Howman-Giles R. Misleading leads: thallium-201 uptake in rebound thymic hyperplasia.Med Pediatr Oncol 1998; 30: 297–300.

    Article  PubMed  CAS  Google Scholar 

  11. Israel O, Front D. Benign mediastinal and parahilar uptake of gallium-67 in treated lymphoma: do we have all the answers?J Nucl Med 1993; 34: 1330–1332.

    PubMed  CAS  Google Scholar 

  12. Patel PM, Alibazoglu H, Ali A, Fordham E, Lamonica G. Normal thymic uptake of FDG on PET imaging.Clin Nucl Med 1996; 21: 772–775.

    Article  PubMed  CAS  Google Scholar 

  13. Brink I, Reinhardt MJ, Hoegerle S, Altehoefer C, Moser E, Nitzsche EU. Increased metabolic activity in the thymus gland studied with18F-FDG PET: age dependency and frequency after chemotherapy.J Nucl Med 2001; 42: 591–595.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shiro Akaki.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akaki, S., Shinya, T., Sato, S. et al. Positive gallium-67 and thallium-201 scans in thymic rebound after chemotherapy for lymphoma. Ann Nucl Med 20, 161–163 (2006). https://doi.org/10.1007/BF02985630

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02985630

Key words

Navigation